國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Lipid signaling in human diseases

Frohman, Michael A.

Lipid signaling in human diseases

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Lipid signaling in human diseasesedited by Julian Gomez-Cambronero, Michael A. Frohman.
其他作者:	Gomez-Cambronero, Julian.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	xiv, 336 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Lipids.
電子資源:	https://doi.org/10.1007/978-3-030-33668-4
ISBN:	9783030336684$q(electronic bk.)

Lipid signaling in human diseases
Lipid signaling in human diseases[electronic resource] /edited by Julian Gomez-Cambronero, Michael A. Frohman. - Cham :Springer International Publishing :2020. - xiv, 336 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2590171-2004 ;. - Handbook of experimental pharmacology ;208..

Part 1. New Roles for Sphingolipid Signaling and Cell Function -- 1. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma -- 2. Exploring the Therapeutic Landscape of Sphingomyelinases -- 3. Sphingosine kinases as druggable targets -- Part 2. Phospholipase D and Mitogen Phosphatidic Acid in Human Disease -- 4. Prospects for PLD inhibition in cancer and thrombotic disease -- 5. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer -- 6. Role of Phospholipase D-Derived Phosphatidic Acid in Regulated Exocytosis and Neurological Disease -- Part 3. Lipid Kinases and Novel Regulatory Pathways -- 7. Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors -- 8. Functions of Nuclear Polyphosphoinositides -- Part 4. Bioactive Lipids in Health and Disease -- 9. Platelet-Activating Factor as an Effector for Environmental Stressors -- 10. Phospholipase D and Choline Metabolism -- Part 5- Lipids and Membrane Microdomains -- 11. Regulation of Inositol Biosynthesis: Balancing Health and Pathophysiology -- 12. Lipids and Membrane Microdomains: The Glycerolipid and Alkylphosphocholine Class of Cancer Chemotherapeutic Drugs -- Part 6. Nuclear Trafficking of Lipids -- 13. Inositide-Dependent Nuclear Signalling in Health and Disease -- 14. Lipids in Exosome Biology.

Lipids are an integral part of cell membrane architecture, are intermediaries in cell metabolism, and are involved in transmitting cell signals from hormones, growth factors and nutrients. A number of lipases and phospholipases, lipid kinases, lipid phosphatases, sphingosine kinases, and their reaction products have been implicated in fundamental cellular processes including cell proliferation, division and migration. These enzymes and their products underlie the molecular mechanisms of numerous human diseases, in particular metabolic disease (diabetes), cancer, neurodegenerative disease and cardiovascular disease. Over the last decade, studies have advanced to the point that a number of inhibitors for these enzymes have been developed to attempt to ameliorate these conditions; some of the inhibitors are currently in human clinical trial. The need for this book is to review the current status of this field and the prospect for the inhibitors to be clinically important.

ISBN: 9783030336684$q(electronic bk.)

Standard No.: 10.1007/978-3-030-33668-4doiSubjects--Topical Terms:

197421
Lipids.

LC Class. No.: QP751 / .L575 2020

Dewey Class. No.: 572.57

Lipid signaling in human diseases
LDR:03464nmm a2200337 a 4500 001 571632
003 DE-He213
005 20200810164006.0
006 m d
007 cr nn 008maaau
008 200922s2020 sz s 0 eng d
020 $a 9783030336684$q(electronic bk.)
020 $a 9783030336677$q(paper)
024 7 $a 10.1007/978-3-030-33668-4 $2 doi
035 $a 978-3-030-33668-4
040 $a GP $c GP
041 0 $a eng
050 4 $a QP751 $b .L575 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 572.57 $2 23
090 $a QP751 $b .L764 2020
245 0 0 $a Lipid signaling in human diseases $h [electronic resource] / $c edited by Julian Gomez-Cambronero, Michael A. Frohman.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a xiv, 336 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.259
505 0 $a Part 1. New Roles for Sphingolipid Signaling and Cell Function -- 1. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma -- 2. Exploring the Therapeutic Landscape of Sphingomyelinases -- 3. Sphingosine kinases as druggable targets -- Part 2. Phospholipase D and Mitogen Phosphatidic Acid in Human Disease -- 4. Prospects for PLD inhibition in cancer and thrombotic disease -- 5. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer -- 6. Role of Phospholipase D-Derived Phosphatidic Acid in Regulated Exocytosis and Neurological Disease -- Part 3. Lipid Kinases and Novel Regulatory Pathways -- 7. Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors -- 8. Functions of Nuclear Polyphosphoinositides -- Part 4. Bioactive Lipids in Health and Disease -- 9. Platelet-Activating Factor as an Effector for Environmental Stressors -- 10. Phospholipase D and Choline Metabolism -- Part 5- Lipids and Membrane Microdomains -- 11. Regulation of Inositol Biosynthesis: Balancing Health and Pathophysiology -- 12. Lipids and Membrane Microdomains: The Glycerolipid and Alkylphosphocholine Class of Cancer Chemotherapeutic Drugs -- Part 6. Nuclear Trafficking of Lipids -- 13. Inositide-Dependent Nuclear Signalling in Health and Disease -- 14. Lipids in Exosome Biology.
520 $a Lipids are an integral part of cell membrane architecture, are intermediaries in cell metabolism, and are involved in transmitting cell signals from hormones, growth factors and nutrients. A number of lipases and phospholipases, lipid kinases, lipid phosphatases, sphingosine kinases, and their reaction products have been implicated in fundamental cellular processes including cell proliferation, division and migration. These enzymes and their products underlie the molecular mechanisms of numerous human diseases, in particular metabolic disease (diabetes), cancer, neurodegenerative disease and cardiovascular disease. Over the last decade, studies have advanced to the point that a number of inhibitors for these enzymes have been developed to attempt to ameliorate these conditions; some of the inhibitors are currently in human clinical trial. The need for this book is to review the current status of this field and the prospect for the inhibitors to be clinically important.
650 0 $a Lipids. $3 197421
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Medical Biochemistry. $3 274286
700 1 $a Gomez-Cambronero, Julian. $3 858349
700 1 $a Frohman, Michael A. $3 858350
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-030-33668-4
950 $a Biomedical and Life Sciences (Springer-11642)